188 related articles for article (PubMed ID: 36860127)
21. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
22. PEXIVAS: The End of Plasmapheresis for ANCA-Associated Vasculitis?
De Vriese AS; Fervenza FC
Clin J Am Soc Nephrol; 2021 Feb; 16(2):307-309. PubMed ID: 32963016
[No Abstract] [Full Text] [Related]
23. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody.
Srivastava A; Rao GK; Segal PE; Shah M; Geetha D
Clin Rheumatol; 2013 Sep; 32(9):1317-22. PubMed ID: 23624587
[TBL] [Abstract][Full Text] [Related]
24. [PEXIVAS-The kiss of death for plasma exchange in ANCA-associated vasculitis?].
Löffler C; Hellmich B
Z Rheumatol; 2020 Nov; 79(9):910-911. PubMed ID: 33025026
[No Abstract] [Full Text] [Related]
25. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange.
Ikeda Y; Fukunari K; Uchiumi S; Awanami Y; Kanaya A; Matsumoto K; Fukuda M; Takashima T; Miyazono M; Ikeda Y
CEN Case Rep; 2020 Feb; 9(1):42-47. PubMed ID: 31612361
[TBL] [Abstract][Full Text] [Related]
26. Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA-associated vasculitis.
Balogun RA; Sanchez AP; Klingel R; Witt V; Aqui N; Meyer E; Padmanabhan A; Pham HP; Schneiderman J; Schwartz J; Wu Y; Zantek ND; Connelly-Smith L; Dunbar NM
J Clin Apher; 2020 Sep; 35(5):493-499. PubMed ID: 32770558
[TBL] [Abstract][Full Text] [Related]
27. [ANCA and anti-MBG double-positive vasculitis: An update on the clinical and therapeutic specificities and comparison with the two eponymous vasculitis].
Philip R; Dumont A; Le Mauff B; Martinet M; Martin Silva N; de Boysson H; Lobbedez T; Aouba A; Deshayes S
Rev Med Interne; 2020 Jan; 41(1):21-26. PubMed ID: 31839271
[TBL] [Abstract][Full Text] [Related]
28. Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline.
Zeng L; Walsh M; Guyatt GH; Siemieniuk RAC; Collister D; Booth M; Brown P; Farrar L; Farrar M; Firth T; Fussner LA; Kilian K; Little MA; Mavrakanas TA; Mustafa RA; Piram M; Stamp LK; Xiao Y; Lytvyn L; Agoritsas T; Vandvik PO; Mahr A
BMJ; 2022 Feb; 376():e064597. PubMed ID: 35217581
[TBL] [Abstract][Full Text] [Related]
29. Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitis.
Gulati K; Edwards H; Prendecki M; Cairns TD; Condon M; Galliford J; Griffith M; Levy JB; Tam FWK; Tanna A; Pusey CD; McAdoo SP
Kidney Int; 2021 Dec; 100(6):1316-1324. PubMed ID: 34560140
[TBL] [Abstract][Full Text] [Related]
30. Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.
Clerte M; Philip R; Levi C; Cornec-Le Gall E; Audard V; Huart A; Puéchal X; Touzot M; Rabot N; Thervet É; Aouba A; Karras A
Scand J Rheumatol; 2022 May; 51(3):205-213. PubMed ID: 34169779
[TBL] [Abstract][Full Text] [Related]
31. Plasma exchange in ANCA-associated vasculitis: the pro position.
Kronbichler A; Shin JI; Wang CS; Szpirt WM; Segelmark M; Tesar V
Nephrol Dial Transplant; 2021 Jan; 36(2):227-231. PubMed ID: 33374018
[TBL] [Abstract][Full Text] [Related]
32. Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature.
Van Gool IC; Kers J; Bakker JA; Rotmans JI; Teng YKO; Bauer MP
Clin Rheumatol; 2022 Oct; 41(10):2949-2960. PubMed ID: 35732985
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.
Noone D; Hebert D; Licht C
Pediatr Nephrol; 2018 Jan; 33(1):1-11. PubMed ID: 27596099
[TBL] [Abstract][Full Text] [Related]
35. The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis.
Walsh M; Collister D; Zeng L; Merkel PA; Pusey CD; Guyatt G; Au Peh C; Szpirt W; Ito-Hara T; Jayne DRW;
BMJ; 2022 Feb; 376():e064604. PubMed ID: 35217545
[TBL] [Abstract][Full Text] [Related]
36. The Effects of Plasma Exchange on Severe Vasculitis with Diffuse Alveolar Hemorrhage.
Goto K; Nakai K; Fujii H; Nishi S
Intern Med; 2017; 56(1):55-59. PubMed ID: 28050000
[TBL] [Abstract][Full Text] [Related]
37. Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.
Sagmeister MS; Weiss M; Eichhorn P; Habicht A; Habersetzer R; Fischereder M; Schönermarck U
BMC Nephrol; 2018 Oct; 19(1):270. PubMed ID: 30340563
[TBL] [Abstract][Full Text] [Related]
38. Relevance of histopathological findings for predictive scoring of short-term treatment response to plasma exchange in severe ANCA-associated renal vasculitides.
Hakroush S; Korsten P; Ströbel P; Tampe B
Front Immunol; 2024; 15():1340999. PubMed ID: 38380320
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis.
Yamada Y; Harada M; Hara Y; Iwabuchi R; Hashimoto K; Yamamoto S; Kamijo Y
Arthritis Res Ther; 2021 Jan; 23(1):28. PubMed ID: 33446268
[TBL] [Abstract][Full Text] [Related]
40. Early and late effects of therapeutic plasma exchange in patients with systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis: A single-center experience.
Al Hamzi HA; Al-Mayouf SM; Al Shaikh AA; Al-Sheikh HA; Alshomar AA; Al Humaidan HA; Al Dalaan AN; Al Saleh SS
Saudi J Kidney Dis Transpl; 2019; 30(4):775-780. PubMed ID: 31464233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
